Duration of Lactation and Maternal Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis
Cardiovascular disease (CVD) is the leading cause of death of women across all ages, and targeting modifiable risk factors, such as those comprised in metabolic syndrome (MetS) (e.g., waist circumference, lipid profile, blood pressure, and blood glucose), is of great importance. An inverse associati...
Main Authors: | Christine Tørris, Ann Kristin Bjørnnes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/9/2718 |
Similar Items
-
Lactation duration and development of type 2 diabetes and metabolic syndrome in postpartum women with recent gestational diabetes mellitus
by: Sasiwan Suthasmalee, et al.
Published: (2024-04-01) -
Reinstitution of pegvaliase therapy during lactation
by: Frances Rohr, et al.
Published: (2022-12-01) -
Differences in Prevalence of Metabolic Syndrome by Breastfeeding Experience of Women in Their 30s and 40s
by: Hye-Jin Kim, MSN, RN, et al.
Published: (2016-06-01) -
Cumulative Lactation and Clinical Metabolic Outcomes at Mid-Life among Women with a History of Gestational Diabetes
by: Pandora L. Wander, et al.
Published: (2022-02-01) -
Beyond the BMI: Validity and Practicality of Postpartum Body Composition Assessment Methods during Lactation: A Scoping Review
by: Caren Biddulph, et al.
Published: (2022-05-01)